Webinar Resources

Fentanyl Strip Testing

This brief video provides an overview of fentanyl strip testing to identify the presence of fentanyl in unregulated drugs for people who use drugs (PWUD). It also includes a brief demo of how to use fentanyl test strip testing to detect the presence of fentanyl in their drug supply. Testing for fentanyl test strips can identify the presence of fentanyl in unregulated drugs. They can be used to test injectable drugs, powders, and pills. Being aware if fentanyl is present allows people to implement appropriate harm reduction strategies to reduce the risk of an overdose. Presented by Sari Frankel, DC Department of Behavioral Health.

Effective Strategies to Enhance Transitions of Care for Justice Involved Populations

This webinar focuses on effective strategies for engaging justice-involved populations and ways to support individuals transitioning to communities. The speakers shared case studies to illustrate the ways that providers have managed transitions of care and supported people. This session is approved by the American Academy of Family Physicians for up to 1 AMA Level 1 CME credit.

Harm Reduction 101: Harm Reduction Basics and Lessons From the Field

People with substance use disorders are at particular risk for overdoses and developing one or more primary conditions or chronic diseases. During this webinar, presenters will discuss harm reduction as a public health approach that aims to reduce harms related to substance use. Presenters will discuss strategies, policies, programs, and practices that aim to minimize negative health, social and legal impacts associated with drug use, drug policies, and drug laws.

Providing Culturally Sensitive, Patient Centered Care

During the webinar, the presenter will focus on ways to address health equity issues and key considerations for providing linguistically effective services. The presenter will discuss best practices and models to support patients in these challenging times.

Understanding the Brain and Treatment for People with Opioid Use Disorders

Understanding the brain chemistry associated with opioid use disorder treatment is essential: Medications for Addiction Treatment (MAT) restores depleted dopamine in the brain so people impacted by OUD can regain functioning. Recognizing this, therapy and support services for OUD are most effective when provided in accordance with a person's healing process and readiness to engage in treatment.

Substance Use Disorders: Screening and Assessment

The American Society of Addiction Medicine (ASAM) has established specific criteria for patient assessments and level of care determinations pertaining to substance use disorder (SUD) – providing the underpinnings for effective treatment and recovery from addiction. This webinar will provide attendees with practical tools and tips for implementation of Screening Brief Intervention and Treatment (SBIRT) including assessments, workflows, and reimbursement.

Stigma, Myth Busters & Engagement Strategies

This webinar will describe how stigma impacts perceptions and resultant SUD care for patients and providers alike. Presenters will also share key concepts and case studies to illustrate ways to address stigma and tools that can be incorporated into their clinical practice.

Integrated Physical and Behavioral Healthcare 102

This webinar will focus on the benefits and outcomes of behavioral health integration and key implementation considerations. The presenters will discuss outcomes that include improving population health, patient experience and reduced costs. The webinar will also feature key integration tips such as building internal support, warm handoffs, establishing workflows among other topics.

Integrating Physical and Behavioral Healthcare 101

This webinar will focus on the foundational concepts of health care integration – including physical and behavioral health – will be reviewed and discussed. The presenters will also focus on integrating substance use disorders and reverse integration.

Addiction Neuroscience 101

This module offers a 25-minute video of the neuroscience of addiction as a chronic brain disease presented by HMA’s Corey Waller, MD, MS, FACEP, DFASAM, with emphasis on Opioid Use Disorder (OUD). "This lecture was developed for audiences of all backgrounds to absorb. From patients to nonspecialist docs. The intent was to move people past the preconceived notion that addiction is a moral failing or choice, to the reality that it is a chronic brain disease that creates maladaptive connections in large swaths of the brain. Over the hundreds of lectures, I have given in my career, I have come to realize that running through 30+ articles in a 70 slide PPT does not move people emotionally. But a good story will. The lecture has coalesced into a story form that is much more compelling than digging through the dense science of voxel dysmorphology, BOLD fMRI technology, and all of the structures postulated to drive craving. If I need a custody officer to "get it" or an administrator to understand the concept, I cannot give them the same lecture I would give a psychiatrist, addiction psychologist, addiction doc, or a neurologist."

Provider Information Session

"The systemic approach to providing person-centered care for a defined population that coordinates physical and behavioral healthcare through a team of primary care and behavioral health practitioners, working with the individuals served, families, and other natural and informal supports. Integrated care models ensure that mental health, substance use disorder, primary care, and specialty services are coordinated and delivered in a manner that is most effective to care for individuals with multiple health care needs and produces the best outcomes."

Treating Addiction in the Setting of COVID-19

Deeper dive on the operational practicalities of delivering MAT and other SUD treatment to clients through telehealth and other remote means; risk and management of relapse and overdose; current expectations regarding privacy rules, documentation, and new regulations from the DEA.

Telehealth Implementation Basics & Payment Updates for COVID-19

The webinar presents policy and reimbursement implications for changes regarding Medicare and Medicaid and the impacts on key provider decisions concerning selecting, implementing, and building a business case for new telehealth services to support patients in these challenging times.

How to Screen and Assess People for Substance Use Disorder

This webinar focused on the appropriate screening and assessments for substance use disorders, including the difference between screening and assessment, brief interventions for substance-related issues, and medications for opioid use disorder.

Enlightened Leadership & High Functioning Teams

An interactive exploration of the foundations of leadership and emotional intelligence, the importance of developing trust among team members, and strategies to channel conflict into a productive and necessary force for innovation.

Strong Patient Engagement Depends on Strong Teams

This webinar includes a refresher on motivational Interviewing, presented tools to strengthen patient engagement and strategies for enhancing and maintaining clinician capacity to work with consistency, presence, and joy in the work.

Stepped Behavioral Care in Primary Care

This webinar presented the Stepped Care Approach, including validated screening tools, strategies and resources for patients with mild, moderate or urgent behavioral health care needs.

Utilizing ADT Alerts for Transitions of Care

This webinar focused on the importance and potential impact of using ADT alerts to manage transitions of care, including an interview with Providence and a system demo from the Medical Home Network in Chicago, IL.
Integrated Care DC is managed by the DC Department of Health Care Finance (DHCF) in partnership with the DC Department of Behavioral Health (DBH). This project is supported by the U.S. Department of Health and Human Services (HHS). A total of $3,500,365, or 81 percent, of the project is financed with federal funds, and $810,022, or 19 percent, is funded by non-federal sources. The contents are those of the author(s) and do not necessarily represent the official views of, or an endorsement by, HHS or the U.S. Government.